首页 > 最新文献

European Journal of Integrative Medicine最新文献

英文 中文
Acupuncture for cyclic and noncyclic breast pain in women: A systematic review and meta-analysis of randomized controlled trials 针灸治疗女性周期性和非周期性乳房疼痛:随机对照试验的系统回顾和元分析
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-03-18 DOI: 10.1016/j.eujim.2024.102355
Hangyu Shi , Huan Chen , Shuai Gao , Jiufei Fang , Lili Zhu , Zhishun Liu

Introduction

Breast pain is a frequently encountered problem in both pre- and postmenopausal women. The pain can be severe and persistent, and interferes with women's daily life. Acupuncture has been widely used for women with cyclic and noncyclic breast pain with possible favorable effects and few adverse events, however, the data have not been systematically reviewed. This systematic review aims to investigate the efficacy of acupuncture on alleviating breast pain.

Methods

Seven databases including Medline, Embase, Pubmed, CNKI, etc. were searched for English and Chinese literature from their inception to 22 January 2024. We included randomized clinical trials that assessed the effectiveness of acupuncture in reducing pain intensity for cyclic and noncyclic mastalgia unrelated to cancer. Two independent reviewers screened the retrieved studies and extracted the data. Risk of bias of included studies was assessed according to Cochrane Risk-of-Bias (RoB) tool version 2. Meta-analysis was conducted where applicable.

Results

Eleven studies were included. Eight studies with 588 women focused on cyclic breast pain (CBP), three studies with 210 women focused on noncyclic breast pain (NCBP). For CBP, the overall response rate of acupuncture was comparable to tamoxifen (3 studies, n=243; RR 1.24, 95% CI 0.75 to 2.06, p=0.39; very low certainty), however, the effect of acupuncture measured by visual analogue scale (VAS) score was inconsistent when compared with sham acupuncture in 3 studies (n=141; MD 11.08, 95% CI -3.95 to 26.10; p = 0.15; very low certainty). For NCBP, acupuncture provided significantly more reduction in VAS score than antibiotics for mastitis (2 studies, n=148; MD 12.69, 95% CI 8.38 to 17.00; p < 0.001; low certainty). A total of five cases of adverse events were reported.

Conclusion

Acupuncture may have similar effects to tamoxifen in treating women with CBP, and may be more effective than antibiotics in alleviating breast pain for women with mastitis. Acupuncture may be an effective complementary treatment for breast pain. However, the overall certainty of evidence was very low. The evidence was not conclusive and requires further investigation with robust methodological quality.

Registration number

CRD42020220134

乳房疼痛是绝经前和绝经后妇女经常遇到的问题。这种疼痛可能是严重的、持续性的,影响妇女的日常生活。针灸已被广泛应用于周期性和非周期性乳房疼痛的妇女,并可能产生良好的效果和较少的不良反应。本系统综述旨在研究针灸对缓解乳房疼痛的疗效。我们检索了 Medline、Embase、Pubmed、CNKI 等 7 个数据库中从开始到 2024 年 1 月 22 日的中英文文献。我们纳入了评估针灸对减轻与癌症无关的周期性和非周期性乳腺痛的疼痛强度的有效性的随机临床试验。两位独立审稿人筛选了检索到的研究并提取了数据。根据 Cochrane Risk-of-Bias (RoB) 工具第 2 版评估了纳入研究的偏倚风险。在适用的情况下进行了元分析。共纳入 11 项研究。其中 8 项研究涉及 588 名女性,主要针对周期性乳房疼痛 (CBP);3 项研究涉及 210 名女性,主要针对非周期性乳房疼痛 (NCBP)。对于 CBP,针灸的总体反应率与他莫昔芬相当(3 项研究,n=243;RR 1.24,95% CI 0.75 至 2.06,p=0.39;非常低的确定性),然而,在 3 项研究中,与假针灸相比,针灸对视觉模拟量表(VAS)评分的影响并不一致(n=141;MD 11.08,95% CI -3.95 至 26.10;p=0.15;非常低的确定性)。就 NCBP 而言,针灸对乳腺炎 VAS 评分的降低幅度明显高于抗生素(2 项研究,n=148;MD 12.69,95% CI 8.38 至 17.00;p <0.001;低确定性)。共有五例不良事件报告。针灸治疗乳腺增生妇女的效果可能与他莫昔芬相似,在缓解乳腺炎妇女的乳房疼痛方面比抗生素更有效。针灸可能是治疗乳房疼痛的有效辅助疗法。然而,证据的总体确定性很低。这些证据并不确凿,需要进一步调查,并采用可靠的方法。CRD42020220134
{"title":"Acupuncture for cyclic and noncyclic breast pain in women: A systematic review and meta-analysis of randomized controlled trials","authors":"Hangyu Shi ,&nbsp;Huan Chen ,&nbsp;Shuai Gao ,&nbsp;Jiufei Fang ,&nbsp;Lili Zhu ,&nbsp;Zhishun Liu","doi":"10.1016/j.eujim.2024.102355","DOIUrl":"10.1016/j.eujim.2024.102355","url":null,"abstract":"<div><h3>Introduction</h3><p>Breast pain is a frequently encountered problem in both pre- and postmenopausal women. The pain can be severe and persistent, and interferes with women's daily life. Acupuncture has been widely used for women with cyclic and noncyclic breast pain with possible favorable effects and few adverse events, however, the data have not been systematically reviewed. This systematic review aims to investigate the efficacy of acupuncture on alleviating breast pain.</p></div><div><h3>Methods</h3><p>Seven databases including Medline, Embase, Pubmed, CNKI, etc. were searched for English and Chinese literature from their inception to 22 January 2024. We included randomized clinical trials that assessed the effectiveness of acupuncture in reducing pain intensity for cyclic and noncyclic mastalgia unrelated to cancer. Two independent reviewers screened the retrieved studies and extracted the data. Risk of bias of included studies was assessed according to Cochrane Risk-of-Bias (RoB) tool version 2. Meta-analysis was conducted where applicable.</p></div><div><h3>Results</h3><p>Eleven studies were included. Eight studies with 588 women focused on cyclic breast pain (CBP), three studies with 210 women focused on noncyclic breast pain (NCBP). For CBP, the overall response rate of acupuncture was comparable to tamoxifen (3 studies, n=243; RR 1.24, 95% CI 0.75 to 2.06, p=0.39; very low certainty), however, the effect of acupuncture measured by visual analogue scale (VAS) score was inconsistent when compared with sham acupuncture in 3 studies (n=141; MD 11.08, 95% CI -3.95 to 26.10; p = 0.15; very low certainty). For NCBP, acupuncture provided significantly more reduction in VAS score than antibiotics for mastitis (2 studies, n=148; MD 12.69, 95% CI 8.38 to 17.00; p &lt; 0.001; low certainty). A total of five cases of adverse events were reported.</p></div><div><h3>Conclusion</h3><p>Acupuncture may have similar effects to tamoxifen in treating women with CBP, and may be more effective than antibiotics in alleviating breast pain for women with mastitis. Acupuncture may be an effective complementary treatment for breast pain. However, the overall certainty of evidence was very low. The evidence was not conclusive and requires further investigation with robust methodological quality.</p></div><div><h3>Registration number</h3><p>CRD42020220134</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"68 ","pages":"Article 102355"},"PeriodicalIF":2.5,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876382024000258/pdfft?md5=242330d87d939a9ef36393d90ecf92ae&pid=1-s2.0-S1876382024000258-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140202221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interactions between vitamin D binding protein variants and major dietary patterns on mental health status in apparently healthy adults 维生素 D 结合蛋白变异与主要膳食模式对表面健康成年人心理健康状况的相互作用
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-03-11 DOI: 10.1016/j.eujim.2024.102352
Yasaman Nasir , Atiyeh Niknam , Mohammad Hossein Rahimi , Mahdi Molahosseini , Khadijeh Mirzaei

Introduction

Recent studies have shown that the risks of mental disorders resulting from vitamin D deficiency, such as depression, anxiety and stress, can be affected by various high-risk alleles. Among the genes interacting with environmental factors are those associated with vitamin D binding protein (DBP) that affects the status of 25- OH vitamin D. Therefore, the present study aimed to determine the interaction between dietary patterns and DBP gene variants on mental health status in adults.

Methods

This cross-sectional study was conducted on a random sample of adult participants (n = 265 and 18–55 years old) in Tehran. Major dietary patterns were determined using principal component analysis (PCA) method on 24 food groups, using a valid and reliable 147-item food frequency questionnaire (FFQ). DBP genotypes were determined by polymerase chain reactions - restriction fragment length polymorphism (PCR-RFLP). Data about the mental health status were collected using the Depression, Anxiety, Stress Score (DASS-21).

Results

Results demonstrated strong interactions between higher adherence to healthy dietary patterns in individuals with the major allele (low-risk allele) carriers of rs7041 (GG genotype), in relation to reduced stress score (OR= -2.54, 95 % CI = -4.60 to -0.48, P interaction = 0.02). Also, individuals with higher adherence to healthy dietary patterns with GG genotype of rs7041 indicated reduced stress score, but it was not significant (OR = -1.84, 95 % CI = 0.18 to -3.86, P interaction = 0.07).

Conclusion

The present evidence indicates that interactions between healthy dietary patterns with DBP variants (rs7041 - GG genotype) may effectively reduce the odds of mental disorders , especially in stress, through consuming healthy food groups and inherited low-risk alleles.

最近的研究表明,因缺乏维生素 D 而导致精神障碍(如抑郁、焦虑和压力)的风险会受到各种高风险等位基因的影响。因此,本研究旨在确定膳食模式和基因变异对成人精神健康状况的相互作用。这项横断面研究是对德黑兰的成年参与者(n=265,18-55 岁)进行随机抽样的。使用有效可靠的 147 项食物频率问卷(FFQ),采用主成分分析法(PCA)确定了 24 种食物的主要饮食模式。通过抑郁、焦虑、压力评分(DASS-21)收集有关心理健康状况的数据。结果表明,rs7041 的主等位基因(低风险等位基因)携带者(GG 基因型)坚持健康饮食模式的程度越高,压力得分越低(OR= -2.54,95% CI = -4.60 至 -0.48,P 交互作用 = 0.02)。此外,rs7041 基因型为 GG 的个体对健康饮食模式的坚持程度越高,压力得分越低,但并不显著(OR = -1.84, 95% CI = 0.18 to -3.86,P 交互作用 = 0.07)。目前的证据表明,健康饮食模式与变异体(rs7041 - GG 基因型)之间的相互作用可通过摄入健康的食物组和遗传低风险等位基因有效降低精神障碍的几率,尤其是压力。
{"title":"Interactions between vitamin D binding protein variants and major dietary patterns on mental health status in apparently healthy adults","authors":"Yasaman Nasir ,&nbsp;Atiyeh Niknam ,&nbsp;Mohammad Hossein Rahimi ,&nbsp;Mahdi Molahosseini ,&nbsp;Khadijeh Mirzaei","doi":"10.1016/j.eujim.2024.102352","DOIUrl":"10.1016/j.eujim.2024.102352","url":null,"abstract":"<div><h3>Introduction</h3><p>Recent studies have shown that the risks of mental disorders resulting from vitamin D deficiency, such as depression, anxiety and stress, can be affected by various high-risk alleles. Among the genes interacting with environmental factors are those associated with vitamin D binding protein (DBP) that affects the status of 25- OH vitamin D. Therefore, the present study aimed to determine the interaction between dietary patterns and <em>DBP</em> gene variants on mental health status in adults.</p></div><div><h3>Methods</h3><p>This cross-sectional study was conducted on a random sample of adult participants (<em>n</em> = 265 and 18–55 years old) in Tehran. Major dietary patterns were determined using principal component analysis (PCA) method on 24 food groups, using a valid and reliable 147-item food frequency questionnaire (FFQ). <em>DBP</em> genotypes were determined by polymerase chain reactions - restriction fragment length polymorphism (PCR-RFLP). Data about the mental health status were collected using the Depression, Anxiety, Stress Score (DASS-21).</p></div><div><h3>Results</h3><p>Results demonstrated strong interactions between higher adherence to healthy dietary patterns in individuals with the major allele (low-risk allele) carriers of rs7041 (GG genotype), in relation to reduced stress score (OR= -2.54, 95 % CI = -4.60 to -0.48, P interaction = 0.02). Also, individuals with higher adherence to healthy dietary patterns with GG genotype of rs7041 indicated reduced stress score, but it was not significant (OR = -1.84, 95 % CI = 0.18 to -3.86, P interaction = 0.07).</p></div><div><h3>Conclusion</h3><p>The present evidence indicates that interactions between healthy dietary patterns with <em>DBP</em> variants (rs7041 - GG genotype) may effectively reduce the odds of mental disorders , especially in stress, through consuming healthy food groups and inherited low-risk alleles.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102352"},"PeriodicalIF":2.5,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140127643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis and network pharmacology-based investigation of Shenqi Fuzheng injection plus docetaxel for the efficacy and molecular mechanism of breast cancer 神七扶正注射液加多西他赛治疗乳腺癌疗效及分子机制的 Meta 分析和网络药理学研究
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-03-06 DOI: 10.1016/j.eujim.2024.102351
Yanqiong Luo, Yujiao Hou, Qian Li, Han Zhang, Moses Manaanye Njolibimi, Wenjing Li, Bo Hong

Introduction

Breast cancer (BC), known as the "pink killer," with a high incidence and poor prognosis, is one of the most prevalent malignant tumors in women. Shenqui Fuzheng injectin (SFI), a kind of Chinese medicine immunomodulator, has the potential to enhance efficacy and reduce toxicity in treating BC in combination with docetaxel (DOC) because of its pharmacological effects of tonifying Qi and strengthening body resistance. Hence, there is an urgent need to summarize the effects of SFI plus DOC on various outcomes in BC patients, and to elucidate the molecular mechanisms of SFI plus DOC anti-BC.

Methods

Studies matching this topic were identified by searching PubMed, Embase, the Cochrane Library, CNKI, CBM, VIP, and the Wanfang database, and screened according to inclusion and exclusion criteria. Two researchers evaluated the methodological quality of the studies using the Cochrane bias risk assessment tool. Review Manager 5.4 and Stata 17.0 were used to conduct the meta-analysis of the extracted data. Network pharmacology and molecular docking were conducted to investigate the potential mechanism of SFI combined with DOC in treating BC.

Results

Overall, 11 studies involving 1280 participants were included. Meta-analysis revealed that SFI plus DOC was beneficial for increasing the objective response rate [RR=1.32, 95 %CI (1.14, 1.51)], improving immune capacity [MD=2.15, 95 %CI (1.41, 2.89)], decreasing tumor marker levels [MD=-11.08, 95 %CI (-13.00, -9.16)], and reducing the incidence of adverse reactions [RR=0.57, 95 %CI (0.47, 0.69)]. Network pharmacology revealed that the 3 most active ingredients were luteolin, quercetin, and kaempferol. The core target genes were ERBB2, EGFR, PIK3CG, GSTP1, TOP2A, and HIF1A. The relevant pathways were the PI3K-AKT signaling pathway and the HIF-1 signaling pathway. Molecular docking showed that the core active ingredients combined well with potential targets.

Conclusion

SFI plus DOC can achieve better therapeutic effects than DOC alone in treating BC. Moreover, SFI combined with DOC may treat BC through a multitarget and multipathway network. Further pharmacological experiments are needed to validate the potential mechanism of SFI combined with DOC in treating BC.

导读:乳腺癌(BC)被称为 "粉红杀手",发病率高,预后差,是女性最常见的恶性肿瘤之一。神阙扶正注射液是一种中药免疫调节剂,因其补气益气、增强机体抵抗力的药理作用,在与多西他赛(DOC)联合治疗乳腺癌方面具有增效减毒的潜力。方法通过检索PubMed、Embase、Cochrane图书馆、CNKI、CBM、VIP和万方数据库,并根据纳入和排除标准进行筛选。两名研究人员使用 Cochrane 偏倚风险评估工具对研究的方法学质量进行了评估。使用Review Manager 5.4和Stata 17.0对提取的数据进行荟萃分析。结果共纳入11项研究,涉及1280名参与者。Meta分析显示,SFI联合DOC有利于提高客观反应率[RR=1.32,95%CI(1.14,1.51)]、改善免疫能力[MD=2.15,95%CI(1.41,2.89)]、降低肿瘤标志物水平[MD=-11.08,95%CI(-13.00,-9.16)]和减少不良反应发生率[RR=0.57,95%CI(0.47,0.69)]。网络药理学显示,3 种最有效的成分是木犀草素、槲皮素和山奈酚。核心靶基因是 ERBB2、EGFR、PIK3CG、GSTP1、TOP2A 和 HIF1A。相关通路为 PI3K-AKT 信号通路和 HIF-1 信号通路。分子对接显示,核心活性成分与潜在靶点结合良好。此外,SFI 联合 DOC 可通过多靶点和多通路网络治疗 BC。要验证 SFI 与 DOC 联合治疗 BC 的潜在机制,还需要进一步的药理实验。
{"title":"Meta-analysis and network pharmacology-based investigation of Shenqi Fuzheng injection plus docetaxel for the efficacy and molecular mechanism of breast cancer","authors":"Yanqiong Luo,&nbsp;Yujiao Hou,&nbsp;Qian Li,&nbsp;Han Zhang,&nbsp;Moses Manaanye Njolibimi,&nbsp;Wenjing Li,&nbsp;Bo Hong","doi":"10.1016/j.eujim.2024.102351","DOIUrl":"10.1016/j.eujim.2024.102351","url":null,"abstract":"<div><h3>Introduction</h3><p>Breast cancer (BC), known as the \"pink killer,\" with a high incidence and poor prognosis, is one of the most prevalent malignant tumors in women. Shenqui Fuzheng injectin (SFI), a kind of Chinese medicine immunomodulator, has the potential to enhance efficacy and reduce toxicity in treating BC in combination with docetaxel (DOC) because of its pharmacological effects of tonifying Qi and strengthening body resistance. Hence, there is an urgent need to summarize the effects of SFI plus DOC on various outcomes in BC patients, and to elucidate the molecular mechanisms of SFI plus DOC anti-BC.</p></div><div><h3>Methods</h3><p>Studies matching this topic were identified by searching PubMed, Embase, the Cochrane Library, CNKI, CBM, VIP, and the Wanfang database, and screened according to inclusion and exclusion criteria. Two researchers evaluated the methodological quality of the studies using the Cochrane bias risk assessment tool. Review Manager 5.4 and Stata 17.0 were used to conduct the meta-analysis of the extracted data. Network pharmacology and molecular docking were conducted to investigate the potential mechanism of SFI combined with DOC in treating BC.</p></div><div><h3>Results</h3><p>Overall, 11 studies involving 1280 participants were included. Meta-analysis revealed that SFI plus DOC was beneficial for increasing the objective response rate [RR=1.32, 95 %CI (1.14, 1.51)], improving immune capacity [MD=2.15, 95 %CI (1.41, 2.89)], decreasing tumor marker levels [MD=-11.08, 95 %CI (-13.00, -9.16)], and reducing the incidence of adverse reactions [RR=0.57, 95 %CI (0.47, 0.69)]. Network pharmacology revealed that the 3 most active ingredients were luteolin, quercetin, and kaempferol. The core target genes were ERBB2, EGFR, PIK3CG, GSTP1, TOP2A, and HIF1A. The relevant pathways were the PI3K-AKT signaling pathway and the HIF-1 signaling pathway. Molecular docking showed that the core active ingredients combined well with potential targets.</p></div><div><h3>Conclusion</h3><p>SFI plus DOC can achieve better therapeutic effects than DOC alone in treating BC. Moreover, SFI combined with DOC may treat BC through a multitarget and multipathway network. Further pharmacological experiments are needed to validate the potential mechanism of SFI combined with DOC in treating BC.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102351"},"PeriodicalIF":2.5,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140087474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kuntai capsule for the treatment of ovulatory disorder infertility: A systematic review and meta-analysis of randomized controlled trials 昆泰胶囊治疗排卵障碍性不孕症:随机对照试验的系统回顾和荟萃分析
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-24 DOI: 10.1016/j.eujim.2024.102350
Xudong Zhang , Xue Bai , Lina Zhang , Ling Xiong , Juwen Zhang , Yun Li , Wenjing Chang , Wei Chen

Introduction

Ovulatory disorders contribute significantly to infertility, due to menstrual cycle disturbances and endocrine abnormalities. Kuntai capsule, a Chinese patent medicine, has been widely used in China to enhance ovarian function and fertility. This review is to evaluate Kuntai capsule's potential benefits and harms for ovulatory disorder infertility (ODI).

Methods

Databases including China National Knowledge Infrastructure, WANFANG Database, Chinese Science and Technology Journal Database, Chinese Biomedical Literature Database, PubMed, Cochrane Library, and Embase were searched from their inception to May 2023. All Randomized Controlled Trials (RCTs) comparing the combination of Kuntai capsule with reproductive medicine to reproductive medicine for ODI were included. Primary outcomes were ovulation rate and pregnancy rate. Secondary outcomes were the number of mature ovarian follicles and adverse events.

Results

Meta-analysis was conducted on 27 RCTs with a total of 2506 patients. The results showed that the combination of Kuntai capsule with clomiphene citrate (CC) had better effect in ovulation rate (Risk Ratio (RR)=1.27, 95 % confidence interval (CI) [1.15, 1.40]) and pregnancy rate (RR=1.66, 95 % CI [1.37, 2.01]) in ODI patients. The combination of Kuntai capsule with letrozole (LE) demonstrated improvements in ovulation rate (RR=1.22, 95 % CI [1.15, 1.29]) and pregnancy rate (RR=1.57, 95 % CI [1.39, 1.77]) in ODI patients. However, further large-scale RCTs are needed to validate these findings.

Conclusion

The combination of Kuntai capsule with reproductive medicine may improve the ovulation rate, pregnancy rate, and number of mature ovarian follicles in patients with ODI. However, considering the methodological quality issues in the included studies, it may potentially affect the reliability of the conclusions to some extent.

导言:由于月经周期紊乱和内分泌异常,排卵障碍是导致不孕不育的重要原因。昆泰胶囊是一种中成药,在中国被广泛用于提高卵巢功能和生育能力。方法检索中国知网、万方数据库、中文科技期刊数据库、中国生物医学文献数据库、PubMed、Cochrane Library和Embase等数据库,检索时间从开始至2023年5月。纳入了所有比较昆泰胶囊与生殖药物联合治疗 ODI 和生殖药物治疗 ODI 的随机对照试验(RCT)。主要结果为排卵率和妊娠率。结果对27项RCT共2506名患者进行了Meta分析。结果显示,坤泰胶囊与枸橼酸氯米芬(CC)联合用药对 ODI 患者的排卵率(风险比(RR)=1.27,95% 置信区间(CI)[1.15, 1.40])和妊娠率(RR=1.66,95% CI [1.37, 2.01])有更好的效果。坤泰胶囊与来曲唑(LE)的联合治疗显示,ODI 患者的排卵率(RR=1.22,95 % CI [1.15,1.29])和妊娠率(RR=1.57,95 % CI [1.39,1.77])均有所改善。结论坤泰胶囊与生殖医学联合应用可提高 ODI 患者的排卵率、妊娠率和成熟卵泡数。然而,考虑到纳入研究的方法学质量问题,可能会在一定程度上影响结论的可靠性。
{"title":"Kuntai capsule for the treatment of ovulatory disorder infertility: A systematic review and meta-analysis of randomized controlled trials","authors":"Xudong Zhang ,&nbsp;Xue Bai ,&nbsp;Lina Zhang ,&nbsp;Ling Xiong ,&nbsp;Juwen Zhang ,&nbsp;Yun Li ,&nbsp;Wenjing Chang ,&nbsp;Wei Chen","doi":"10.1016/j.eujim.2024.102350","DOIUrl":"https://doi.org/10.1016/j.eujim.2024.102350","url":null,"abstract":"<div><h3>Introduction</h3><p>Ovulatory disorders contribute significantly to infertility, due to menstrual cycle disturbances and endocrine abnormalities. Kuntai capsule, a Chinese patent medicine, has been widely used in China to enhance ovarian function and fertility<strong>.</strong> This review is to evaluate Kuntai capsule's potential benefits and harms for ovulatory disorder infertility (ODI).</p></div><div><h3>Methods</h3><p>Databases including China National Knowledge Infrastructure, WANFANG Database, Chinese Science and Technology Journal Database, Chinese Biomedical Literature Database, PubMed, Cochrane Library, and Embase were searched from their inception to May 2023. All Randomized Controlled Trials (RCTs) comparing the combination of Kuntai capsule with reproductive medicine to reproductive medicine for ODI were included. Primary outcomes were ovulation rate and pregnancy rate. Secondary outcomes were the number of mature ovarian follicles and adverse events.</p></div><div><h3>Results</h3><p>Meta-analysis was conducted on 27 RCTs with a total of 2506 patients. The results showed that the combination of Kuntai capsule with clomiphene citrate (CC) had better effect in ovulation rate (Risk Ratio (RR)=1.27, 95 % confidence interval (CI) [1.15, 1.40]) and pregnancy rate (RR=1.66, 95 % CI [1.37, 2.01]) in ODI patients. The combination of Kuntai capsule with letrozole (LE) demonstrated improvements in ovulation rate (RR=1.22, 95 % CI [1.15, 1.29]) and pregnancy rate (RR=1.57, 95 % CI [1.39, 1.77]) in ODI patients. However, further large-scale RCTs are needed to validate these findings.</p></div><div><h3>Conclusion</h3><p>The combination of Kuntai capsule with reproductive medicine may improve the ovulation rate, pregnancy rate, and number of mature ovarian follicles in patients with ODI. However, considering the methodological quality issues in the included studies, it may potentially affect the reliability of the conclusions to some extent.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102350"},"PeriodicalIF":2.5,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876382024000209/pdfft?md5=7e25ac5f13ab9f66a31693a9a8cd46cf&pid=1-s2.0-S1876382024000209-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140190826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring why individuals utilise naturopathic treatment and choose to combine naturopathy with biomedicine 探索个人利用自然疗法治疗和选择将自然疗法与生物医学相结合的原因
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-22 DOI: 10.1016/j.eujim.2024.102347
Asmita Patel , Robyn Carruthers , Wayne Hill , Karen Wesseling , Karen Mees

Introduction

There has been a global increase in the utilisation of traditional, complementary, and integrative medicine (TCIM), including that of naturopathy. Limited New Zealand research exists that has examined why individuals use naturopathic treatment, and why in some cases, naturopathy is combined with biomedicine. The present study had two main aims: (1) To identify why individuals utilise naturopathic treatment, and (2) to identify why individuals choose to combine naturopathy with biomedicine in the management of chronic health conditions or ongoing symptoms.

Methods

Participants were 20 clients who attended a student naturopathy and herbal medicine teaching clinic in Auckland, New Zealand. Participants were individually interviewed. A structured interview schedule comprising of open-ended questions was used. Data was analysed using an inductive thematic approach.

Results

Five main themes were identified in relation to why individuals utilised naturopathic treatment and combined naturopathy with biomedicine in the management of their chronic health conditions or ongoing symptoms: (1) A holistic approach, (2) a new and different approach, (3) wanting to utilise natural remedies, (4) previous use of naturopathic treatment and/or other forms of TCIM, and (5) word-of-mouth: the role of family and friends in influencing the utilisation of naturopathic treatment.

Conclusions

There was an alignment between what participants desired to seek from naturopathic treatment and the philosophy and core naturopathic treatment principles: a holistic approach to health and healing and the utilisation of natural remedies. Participants combined naturopathic treatment with biomedicine, as it allowed for the use of natural and less invasive ways in treating and managing some of their symptoms. Integration of treatment modalities allowed individuals to retain some control over how their body was treated. Previous use of naturopathy and/or other forms of TCIM influenced current utilisation of naturopathy, either for the same condition or for new condition(s). Family and friends also had a salient role in influencing individuals to seek naturopathic treatment.

导言:在全球范围内,包括自然疗法在内的传统医学、补充医学和综合医学(TCIM)的使用率不断上升。新西兰对个人为何使用自然疗法以及在某些情况下自然疗法为何与生物医学相结合的研究有限。本研究有两个主要目的:(1) 找出个人使用自然疗法的原因;(2) 找出个人选择将自然疗法与生物医学相结合来治疗慢性疾病或持续症状的原因。我们对参与者进行了单独访谈。访谈采用结构化访谈表,包含开放式问题。结果在个人利用自然疗法治疗以及将自然疗法与生物医学相结合治疗其慢性疾病或持续症状的原因方面,确定了五大主题:(1) 整体方法;(2) 新的不同方法;(3) 希望利用自然疗法;(4) 以前使用过自然疗法治疗和/或其他形式的 TCIM;(5) 口碑:家人和朋友在影响利用自然疗法治疗方面所起的作用。结论参与者希望从自然疗法中获得的治疗与自然疗法的理念和核心治疗原则是一致的:整体健康和治疗方法以及自然疗法的使用。参与者将自然疗法与生物医学结合起来,因为自然疗法可以使用自然的、创伤较小的方法来治疗和控制他们的一些症状。治疗方式的结合使患者能够在一定程度上控制自己身体的治疗方式。曾经使用过自然疗法和/或其他形式的 TCIM 会影响目前对自然疗法的使用,无论是治疗相同的病症还是新的病症。家人和朋友在影响个人寻求自然疗法治疗方面也发挥了重要作用。
{"title":"Exploring why individuals utilise naturopathic treatment and choose to combine naturopathy with biomedicine","authors":"Asmita Patel ,&nbsp;Robyn Carruthers ,&nbsp;Wayne Hill ,&nbsp;Karen Wesseling ,&nbsp;Karen Mees","doi":"10.1016/j.eujim.2024.102347","DOIUrl":"10.1016/j.eujim.2024.102347","url":null,"abstract":"<div><h3>Introduction</h3><p>There has been a global increase in the utilisation of traditional, complementary, and integrative medicine (TCIM), including that of naturopathy. Limited New Zealand research exists that has examined why individuals use naturopathic treatment, and why in some cases, naturopathy is combined with biomedicine. The present study had two main aims: (1) To identify why individuals utilise naturopathic treatment, and (2) to identify why individuals choose to combine naturopathy with biomedicine in the management of chronic health conditions or ongoing symptoms.</p></div><div><h3>Methods</h3><p>Participants were 20 clients who attended a student naturopathy and herbal medicine teaching clinic in Auckland, New Zealand. Participants were individually interviewed. A structured interview schedule comprising of open-ended questions was used. Data was analysed using an inductive thematic approach.</p></div><div><h3>Results</h3><p>Five main themes were identified in relation to why individuals utilised naturopathic treatment and combined naturopathy with biomedicine in the management of their chronic health conditions or ongoing symptoms: (1) A holistic approach, (2) a new and different approach, (3) wanting to utilise natural remedies, (4) previous use of naturopathic treatment and/or other forms of TCIM, and (5) word-of-mouth: the role of family and friends in influencing the utilisation of naturopathic treatment.</p></div><div><h3>Conclusions</h3><p>There was an alignment between what participants desired to seek from naturopathic treatment and the philosophy and core naturopathic treatment principles: a holistic approach to health and healing and the utilisation of natural remedies. Participants combined naturopathic treatment with biomedicine, as it allowed for the use of natural and less invasive ways in treating and managing some of their symptoms. Integration of treatment modalities allowed individuals to retain some control over how their body was treated. Previous use of naturopathy and/or other forms of TCIM influenced current utilisation of naturopathy, either for the same condition or for new condition(s). Family and friends also had a salient role in influencing individuals to seek naturopathic treatment.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102347"},"PeriodicalIF":2.5,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the potential of Cytisus purgans as a source of bioactive molecules: In vitro pharmacological evaluation 探究作为生物活性分子来源的蓝莓的潜力:体外药理学评估
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-21 DOI: 10.1016/j.eujim.2024.102349
Safa Chaira , Badra Bouzghaia , Mourad Hanfer , Imededdine Kaddi , Mohammed Tahar Ben Moussa , Patrick Pale , Hassina Harkat

Introduction

Cytisus purgans is an uncommon species found in Algeria (Aures, Mahdids and Lella Khadidja). In the current study, we present, to the best of our knowledge, the first detailed chemical profile of its extracts and collect various pieces of evidence that underscore their therapeutic potential.

Methods

The ethyl acetate extract (EAE) of C. purgans was purified using different chromatographic methods. The bioactive compounds obtained were analysed by NMR and mass spectroscopy to identify their structures. The therapeutic potential of the extracts was investigated using several in vitro assays.

Results and discussion

The developed spectral analysis techniques enabled the structural elucidation of seven compounds. The analysis identified four isoflavones, including daidzein, genistein, isoprunetin and biochanin A. Additionally, one flavone, chrysin and one flavonol, quercetin, were positively identified. Notably, the phytosterol daucosterol was also isolated and characterised. The studied extracts were found to be rich in polyphenols and flavonoids. The EAE had the highest polyphenolic (163.85 ± 3.82 mg GAE/g dry extract) and flavonoid content (180.84 ± 3.68 mg QE/g dry extract). The extracts showed potent anti-oxidant activity, as demonstrated by DPPH 50 % inhibitory concentration (EAE: IC50 = 26.66 µg/mL, BuE: IC50 = 30.91 µg/mL), ferric reducing anti-oxidant power IC50 (EAE: IC50 = 6.37 ± 0.27 µg/mL, BuE: IC50 = 13.02 ± 0.1 µg/mL) and total anti-oxidant capacity values (EAE 106.57 ± 5.81 AAE/g dry extract, BuE 105.46 ± 8.64 AAE/g dry extract). This anti-oxidant activity contributed significantly to effective sun protection (EAE sun protection factor (SPF) = 87.84, BuE SPF = 31.67). Additionally, the extracts inhibited acetylcholinesterase (EAE IC50 = 24.40 ± 2.84 µg/mL, BuE IC50 = 68.07 ± 02.26 µg/mL) and butyrylcholinesterase enzymes (EAE IC50 = 36.39 ± 0.75 µg/mL, BuE IC50 = 66.19 ± 01.25 µg/mL) the most and significantly inhibited urease (EAE IC50 = 77.82 ± 4.59 µg/mL, BuE IC50 = 127.05 ± 2.87 µg/mL).

Conclusion

Considering the findings, C. purgans emerges as a promising reservoir of bioactive compounds that have the potential to contribute to the development of treatments for specific diseases. The identification of these compounds and their therapeutic potential provides valuable insights into their potential use in drug development.

导言Cytisus purgans是阿尔及利亚(Aures、Mahdids和Lella Khadidja)的一种不常见物种。在当前的研究中,据我们所知,我们首次对其提取物进行了详细的化学分析,并收集了强调其治疗潜力的各种证据。方法采用不同的色谱法对 C. purgans 的乙酸乙酯提取物(EAE)进行纯化。通过核磁共振和质谱分析获得的生物活性化合物,以确定其结构。结果与讨论所开发的光谱分析技术使 7 种化合物的结构得以阐明。分析确定了四种异黄酮,包括大黄素、染料木素、异黄酮素和生物黄酮 A。值得注意的是,还分离出了植物甾醇 daucosterol 并对其进行了鉴定。研究发现,这些提取物富含多酚和类黄酮。EAE 的多酚含量(163.85 ± 3.82 毫克 GAE/克干提取物)和类黄酮含量(180.84 ± 3.68 毫克 QE/克干提取物)最高。这些提取物具有很强的抗氧化活性,如 DPPH 50 % 抑制浓度(EAE:IC50 = 26.66 µg/mL,BuE:IC50 = 30.91 µg/mL)、铁还原抗氧化能力 IC50(EAE:IC50 = 6.37 ± 0.27 µg/mL, BuE: IC50 = 13.02 ± 0.1 µg/mL) 和总抗氧化能力值(EAE 106.57 ± 5.81 AAE/g 干提取物,BuE 105.46 ± 8.64 AAE/g 干提取物)。这种抗氧化活性大大提高了防晒效果(EAE 防晒系数 (SPF) = 87.84,BuE SPF = 31.67)。此外,萃取物对乙酰胆碱酯酶(EAE IC50 = 24.40 ± 2.84 µg/mL, BuE IC50 = 68.07 ± 02.26 µg/mL)和丁酰胆碱酯酶(EAE IC50 = 36.39 ± 0.75 µg/mL, BuE IC50 = 66.19 ± 01.25 µg/mL)的抑制作用最强,对脲酶(EAE IC50 = 77.结论考虑到这些发现,C. purgans 是一个很有前景的生物活性化合物库,有可能有助于开发治疗特定疾病的方法。对这些化合物及其治疗潜力的鉴定为它们在药物开发中的潜在用途提供了宝贵的见解。
{"title":"Exploring the potential of Cytisus purgans as a source of bioactive molecules: In vitro pharmacological evaluation","authors":"Safa Chaira ,&nbsp;Badra Bouzghaia ,&nbsp;Mourad Hanfer ,&nbsp;Imededdine Kaddi ,&nbsp;Mohammed Tahar Ben Moussa ,&nbsp;Patrick Pale ,&nbsp;Hassina Harkat","doi":"10.1016/j.eujim.2024.102349","DOIUrl":"10.1016/j.eujim.2024.102349","url":null,"abstract":"<div><h3>Introduction</h3><p><em>Cytisus purgans</em> is an uncommon species found in Algeria (Aures, Mahdids and Lella Khadidja). In the current study, we present, to the best of our knowledge, the first detailed chemical profile of its extracts and collect various pieces of evidence that underscore their therapeutic potential.</p></div><div><h3>Methods</h3><p>The ethyl acetate extract (EAE) of <em>C. purgans</em> was purified using different chromatographic methods. The bioactive compounds obtained were analysed by NMR and mass spectroscopy to identify their structures. The therapeutic potential of the extracts was investigated using several in vitro assays.</p></div><div><h3>Results and discussion</h3><p>The developed spectral analysis techniques enabled the structural elucidation of seven compounds. The analysis identified four isoflavones, including daidzein, genistein, isoprunetin and biochanin A. Additionally, one flavone, chrysin and one flavonol, quercetin, were positively identified. Notably, the phytosterol daucosterol was also isolated and characterised. The studied extracts were found to be rich in polyphenols and flavonoids. The EAE had the highest polyphenolic (163.85 ± 3.82 mg GAE/g dry extract) and flavonoid content (180.84 ± 3.68 mg QE/g dry extract). The extracts showed potent anti-oxidant activity, as demonstrated by DPPH 50 % inhibitory concentration (EAE: IC<sub>50</sub> = 26.66 µg/mL, BuE: IC<sub>50</sub> = 30.91 µg/mL), ferric reducing anti-oxidant power IC<sub>50</sub> (EAE: IC<sub>50</sub> = 6.37 ± 0.27 µg/mL, BuE: IC<sub>50</sub> = 13.02 ± 0.1 µg/mL) and total anti-oxidant capacity values (EAE 106.57 ± 5.81 AAE/g dry extract, BuE 105.46 ± 8.64 AAE/g dry extract). This anti-oxidant activity contributed significantly to effective sun protection (EAE sun protection factor (SPF) = 87.84, BuE SPF = 31.67). Additionally, the extracts inhibited acetylcholinesterase (EAE IC<sub>50</sub> = 24.40 ± 2.84 µg/mL, BuE IC<sub>50</sub> = 68.07 ± 02.26 µg/mL) and butyrylcholinesterase enzymes (EAE IC<sub>50</sub> = 36.39 ± 0.75 µg/mL, BuE IC<sub>50</sub> = 66.19 ± 01.25 µg/mL) the most and significantly inhibited urease (EAE IC<sub>50</sub> = 77.82 ± 4.59 µg/mL, BuE IC<sub>50</sub> = 127.05 ± 2.87 µg/mL).</p></div><div><h3>Conclusion</h3><p>Considering the findings, <em>C. purgans</em> emerges as a promising reservoir of bioactive compounds that have the potential to contribute to the development of treatments for specific diseases. The identification of these compounds and their therapeutic potential provides valuable insights into their potential use in drug development.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102349"},"PeriodicalIF":2.5,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating yoga into comprehensive cancer care: Starting somewhere 将瑜伽融入癌症综合治疗:从某处开始
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-21 DOI: 10.1016/j.eujim.2024.102348
Kathryn M. Glaser , Christina R. Crabtree-Ide , Tessa F. Flores , Mary E. Reid

Introduction

The rapid increase in cancer survivors in the United States (US) highlights the importance of survivors’ long-term care needs and symptom management. Given evidence that yoga supports cancer related symptoms, our aim was to develop and implement a community yoga program available for cancer survivors, family members, and staff involved in cancer care at a public comprehensive cancer center in the US. Given the wide age range and potential side effects from cancer treatment, we adapted the yoga program to meet the needs of cancer survivors.

Methods

Beginning in May 2017, we offered sixty-minute gentle yoga sessions for all medically cleared cancer survivors and their family members, caregivers, and friends, as well as oncology staff. We aimed to evaluate acceptability, development, and implementation of an adaptive yoga program at our comprehensive cancer center using mixed methods. Classes were initially offered once a week, then increased to twice a week. A total of five service evaluations were sent approximately every six months between April 2018-October 2019 to evaluate participant satisfaction (n = 90 responses). Qualitative data were collected and analyzed using thematic analysis of participant satisfaction, allowing us to continuously monitor the yoga program and adjust to meet participants’ needs.

Results

Between May 2017 and February 2020, 176 people attended our program. Ages ranged from 21 to 72 years, with an average age of 45 years. Based on these evaluations, 96 % (n = 86) of participants rated both the program and teachers excellent, and 4 % (n = 4) rated the program and teachers good. Qualitative themes highlighted positive aspects of the program, including accessibility, inclusivity, and adaptive yoga based on medical needs, skill level, and abilities.

Conclusions

Adaptive yoga programs are well-accepted by cancer survivors and caregivers, and may contribute a solution to healthcare staff and physician burnout. It is essential to build a solid foundation of self-care and wellness programming for cancer survivors and to create and foster adaptive yoga classes. Next steps for our program include evaluating yoga within the clinical setting, including chemotherapy infusion centers, and further research on reduction in stress through yoga in cancer survivors.

导言:美国癌症幸存者人数的快速增长凸显了幸存者长期护理需求和症状管理的重要性。鉴于有证据表明瑜伽对癌症相关症状有帮助,我们的目标是开发并实施一项社区瑜伽计划,供美国一家公立综合癌症中心的癌症幸存者、家庭成员和癌症护理人员使用。考虑到癌症患者的年龄跨度较大,以及癌症治疗可能产生的副作用,我们对瑜伽课程进行了调整,以满足癌症幸存者的需求。方法从 2017 年 5 月开始,我们为所有通过医学检查的癌症幸存者及其家人、护理人员和朋友以及肿瘤科工作人员提供 60 分钟的温和瑜伽课程。我们旨在采用混合方法评估综合癌症中心适应性瑜伽课程的可接受性、发展和实施情况。课程最初每周一次,后来增加到每周两次。在 2018 年 4 月至 2019 年 10 月期间,大约每六个月共发出五份服务评价,以评估参与者的满意度(n = 90 份回复)。我们通过对参与者满意度的主题分析来收集和分析定性数据,从而对瑜伽项目进行持续监控,并根据参与者的需求进行调整。结果在 2017 年 5 月至 2020 年 2 月期间,共有 176 人参加了我们的项目。年龄从 21 岁到 72 岁不等,平均年龄为 45 岁。根据这些评价,96%(n = 86)的参与者将课程和教师都评为优秀,4%(n = 4)的参与者将课程和教师评为良好。定性主题强调了该计划的积极方面,包括可及性、包容性以及基于医疗需求、技能水平和能力的适应性瑜伽。结论适应性瑜伽计划深受癌症幸存者和护理人员的认可,并可能有助于解决医护人员和医生的职业倦怠问题。为癌症幸存者的自我保健和健康计划打下坚实的基础,并创建和促进适应性瑜伽课程是非常重要的。我们计划的下一步包括评估临床环境中的瑜伽,包括化疗输液中心,以及进一步研究通过瑜伽减轻癌症幸存者的压力。
{"title":"Integrating yoga into comprehensive cancer care: Starting somewhere","authors":"Kathryn M. Glaser ,&nbsp;Christina R. Crabtree-Ide ,&nbsp;Tessa F. Flores ,&nbsp;Mary E. Reid","doi":"10.1016/j.eujim.2024.102348","DOIUrl":"10.1016/j.eujim.2024.102348","url":null,"abstract":"<div><h3>Introduction</h3><p>The rapid increase in cancer survivors in the United States (US) highlights the importance of survivors’ long-term care needs and symptom management. Given evidence that yoga supports cancer related symptoms, our aim was to develop and implement a community yoga program available for cancer survivors, family members, and staff involved in cancer care at a public comprehensive cancer center in the US. Given the wide age range and potential side effects from cancer treatment, we adapted the yoga program to meet the needs of cancer survivors.</p></div><div><h3>Methods</h3><p>Beginning in May 2017, we offered sixty-minute gentle yoga sessions for all medically cleared cancer survivors and their family members, caregivers, and friends, as well as oncology staff. We aimed to evaluate acceptability, development, and implementation of an adaptive yoga program at our comprehensive cancer center using mixed methods. Classes were initially offered once a week, then increased to twice a week. A total of five service evaluations were sent approximately every six months between April 2018-October 2019 to evaluate participant satisfaction (<em>n</em> = 90 responses). Qualitative data were collected and analyzed using thematic analysis of participant satisfaction, allowing us to continuously monitor the yoga program and adjust to meet participants’ needs.</p></div><div><h3>Results</h3><p>Between May 2017 and February 2020, 176 people attended our program. Ages ranged from 21 to 72 years, with an average age of 45 years. Based on these evaluations, 96 % (<em>n</em> = 86) of participants rated both the program and teachers excellent, and 4 % (<em>n</em> = 4) rated the program and teachers good. Qualitative themes highlighted positive aspects of the program, including accessibility, inclusivity, and adaptive yoga based on medical needs, skill level, and abilities.</p></div><div><h3>Conclusions</h3><p>Adaptive yoga programs are well-accepted by cancer survivors and caregivers, and may contribute a solution to healthcare staff and physician burnout. It is essential to build a solid foundation of self-care and wellness programming for cancer survivors and to create and foster adaptive yoga classes. Next steps for our program include evaluating yoga within the clinical setting, including chemotherapy infusion centers, and further research on reduction in stress through yoga in cancer survivors.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"67 ","pages":"Article 102348"},"PeriodicalIF":2.5,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139954064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The add-on effect of oral East Asian herbal medicine to steroid therapy for alopecia areata: A systematic review and meta-analysis 口服东亚草药对类固醇疗法治疗斑秃的辅助效果:系统回顾与荟萃分析
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-17 DOI: 10.1016/j.eujim.2024.102345
Soojin Park , Jieun Lee , Seoyeon Jun , Kyuseok Kim

Introduction

Alopecia areata (AA) is an autoimmune disease that degrades patients' quality of life and adversely affects mental health. Since steroid therapy (ST) has limited efficacy and a risk of recurrence, East Asian herbal medicine (EAHM) combined with ST has been suggested as an alternative treatment. Many randomized controlled trials (RCTs) have been conducted on the efficacy of EAHM combined with ST in AA treatment; however, the efficacy of EAHM combined with ST and the treatment effects of ST alone have not yet been compared. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of the combination of ST and EAHM compared to ST alone in the treatment of AA.

Methods

We searched 10 databases: PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, KoreaMed, Korean Medical Database (KMBASE), Korean Studies Information Service System (KISS), ScienceON, and Korea Science. Bias was independently assessed using Cochrane Risk of Bias tool (RoB 2.0), and meta-analysis was conducted using Review Manager (Revman) 5.4.1 with the application of random-effect models. The primary outcome was defined as the cure rate.

Results

Fifteen studies were selected, and 1,119 participants were included in the study. According to the results of the meta-analysis, a higher cure rate (RR 1.50, 95 % CI : 1.31, 1.71, P<0.00001, I2=0 %), a higher total efficacy rate (modified Total Efficacy Rate 1 (mTER1); (RR 1.10, 95 % CI: 1,06, 1.15, P < 0.00001, I2=0 %), modified Total Efficacy Rate 2 (mTER2); (RR 1.09, 95 % CI: 1.03, 1.16, P = 0.006, I2=0 %)), and a lower recurrence rate (RR 0.28, 95 % CI: 0.16, 0.48, P<0.00001, I2=0 % %) were confirmed in the ST with EAHM group than in the ST group. Low IFN-γ levels and high IL-10 levels were identified in the ST combined with EAHM group. No serious adverse effects were observed during treatment.

Conclusions

Compared to ST alone in AA treatment, the combination treatment of ST and EAHM may effectively and safely increase the cure and total efficacy rates and may lower the recurrence rate. However, to strengthen the basis of this review, higher quality RCTs must be performed.

Registration

CRD42023397023

斑秃(AA)是一种自身免疫性疾病,会降低患者的生活质量并对心理健康产生不利影响。由于类固醇疗法(ST)疗效有限,且有复发风险,因此有人建议将东亚草药疗法(EAHM)与类固醇疗法相结合,作为一种替代治疗方法。目前已有许多随机对照试验(RCT)研究了东亚中药与类固醇疗法联合治疗 AA 的疗效,但尚未对东亚中药与类固醇疗法联合治疗 AA 的疗效与单独使用类固醇疗法的疗效进行比较。本系统综述和荟萃分析旨在评估 ST 和 EAHM 联合治疗 AA 的有效性和安全性。我们检索了 10 个数据库:PubMed、EMBASE、Cochrane Library、中国国家知识基础设施(CNKI)、万方、KoreaMed、韩国医学数据库(KMBASE)、韩国研究信息服务系统(KISS)、ScienceON和韩国科学。使用 Cochrane Risk of Bias 工具(RoB 2.0)对偏倚进行了独立评估,并使用 Review Manager (Revman) 5.4.1 应用随机效应模型进行了荟萃分析。主要结果定义为治愈率。研究选取了 15 项研究,共纳入 1,119 名参与者。根据荟萃分析的结果,较高的治愈率(RR 1.50,95% CI : 1.31, 1.71,P<0.00001,I=0%)、较高的总有效率(修改后的总有效率 1 (mTER1);(RR 1.10,95% CI : 1,06, 1.15,P<0.00001,I=0%)、改良总有效率2(mTER2);(RR 1.09,95% CI:1.03,1.16,P=0.006,I=0%)),以及较低的复发率(RR 0.28,95% CI:0.16,0.48,P<0.00001,I=0%)均证实ST伴EAHM组低于ST组。ST联合EAHM组的IFN-γ水平较低,IL-10水平较高。治疗期间未观察到严重的不良反应。与单用 ST 治疗 AA 相比,ST 和 EAHM 联合治疗可有效、安全地提高治愈率和总有效率,并可降低复发率。然而,为了加强这项研究的基础,必须进行更高质量的研究性临床试验。CRD42023397023
{"title":"The add-on effect of oral East Asian herbal medicine to steroid therapy for alopecia areata: A systematic review and meta-analysis","authors":"Soojin Park ,&nbsp;Jieun Lee ,&nbsp;Seoyeon Jun ,&nbsp;Kyuseok Kim","doi":"10.1016/j.eujim.2024.102345","DOIUrl":"10.1016/j.eujim.2024.102345","url":null,"abstract":"<div><h3>Introduction</h3><p>Alopecia areata (AA) is an autoimmune disease that degrades patients' quality of life and adversely affects mental health. Since steroid therapy (ST) has limited efficacy and a risk of recurrence, East Asian herbal medicine (EAHM) combined with ST has been suggested as an alternative treatment. Many randomized controlled trials (RCTs) have been conducted on the efficacy of EAHM combined with ST in AA treatment; however, the efficacy of EAHM combined with ST and the treatment effects of ST alone have not yet been compared. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of the combination of ST and EAHM compared to ST alone in the treatment of AA.</p></div><div><h3>Methods</h3><p>We searched 10 databases: PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang, KoreaMed, Korean Medical Database (KMBASE), Korean Studies Information Service System (KISS), ScienceON, and Korea Science. Bias was independently assessed using Cochrane Risk of Bias tool (RoB 2.0), and meta-analysis was conducted using Review Manager (Revman) 5.4.1 with the application of random-effect models. The primary outcome was defined as the cure rate.</p></div><div><h3>Results</h3><p>Fifteen studies were selected, and 1,119 participants were included in the study. According to the results of the meta-analysis, a higher cure rate (RR 1.50, 95 % CI : 1.31, 1.71, <em>P</em>&lt;0.00001, I<sup>2</sup>=0 %), a higher total efficacy rate (modified Total Efficacy Rate 1 (mTER1); (RR 1.10, 95 % CI: 1,06, 1.15, <em>P</em> &lt; 0.00001, I<sup>2</sup>=0 %), modified Total Efficacy Rate 2 (mTER2); (RR 1.09, 95 % CI: 1.03, 1.16, <em>P</em> = 0.006, I<sup>2</sup>=0 %)), and a lower recurrence rate (RR 0.28, 95 % CI: 0.16, 0.48, <em>P</em>&lt;0.00001, I<sup>2</sup>=0 % %) were confirmed in the ST with EAHM group than in the ST group. Low IFN-γ levels and high IL-10 levels were identified in the ST combined with EAHM group. No serious adverse effects were observed during treatment.</p></div><div><h3>Conclusions</h3><p>Compared to ST alone in AA treatment, the combination treatment of ST and EAHM may effectively and safely increase the cure and total efficacy rates and may lower the recurrence rate. However, to strengthen the basis of this review, higher quality RCTs must be performed.</p></div><div><h3>Registration</h3><p>CRD42023397023</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"68 ","pages":"Article 102345"},"PeriodicalIF":2.5,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139920521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of catgut embedding in patients with obesity of gastrointestinal internal heat: A randomised controlled trial 胃肠道内热肥胖症患者的猫肠嵌入术效果:随机对照试验
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-01 DOI: 10.1016/j.eujim.2023.102327
Qingqing Zhu , Jian Cheng , Xiaolan Xu , Tangying Xu , Xingjiang Gu , Yun Xia , Lingzhen Mao , Nannan Hu , Yuexia Fang

Introduction

Globally, the incidence of obesity is increasing, causing increased rates of hypertension, diabetes, and cardiovascular diseases. Acupoint catgut embedding, a popular acupuncture method in China, has greater efficacy than acupuncture for weight control. The effectiveness of catgut embedding in patients with fatty liver associated with metabolic dysfunction was investigated.

Methods

In this randomised controlled trial, 60 patients with gastrointestinal internal heat-type obesity were randomised to the intervention (n = 30) and control (n = 30) groups. The intervention group participated in the catgut embeddings with diet and exercise for 2 months, with a catgut treatment frequency of once every 10 days for 30 min. The control group participated only in diet and exercise for the same period. Body weight; body mass index (BMI); waist-to-hip ratio (WHR); fasting plasma glucose, 2-hour blood glucose, glycated haemoglobin, and lipid levels were assessed before and after treatments.

Results

Fifty-seven patients completed the courses. After 2 months, the intervention group showed a statistically significant trend of decrease in WHR and total score of gastrointestinal internal heat-type clinical symptoms when compared with the control group (mean difference: −0.03, 95 % confidence level [CI]: −0.07 to 0.00 and mean difference: −6.04, 95 % CI: −8.59 to −3.50, respectively). In the intervention group, the mean reductions in body weight and BMI were 6.18 kg (95 % CI: 4.60 to 7.76) and 2.23 kg/m2 (95 % CI: 1.72 to 2.74), respectively. The total treatment efficiency for fatty liver in the intervention and control groups was 61.5 % and 30.8 %, respectively (risk ratio: 3.60; 95 % CI: 1.14 to 11.35).

Conclusion

Catgut embedding administered with diet and exercise is effective for patients with gastrointestinal internal heat-type obesity and some patients with obesity complicated by metabolic dysfunction-associated fatty liver disease. The effects observed in the intervention group were superior to those in the control group in terms of body weight, BMI, WHR, total score of gastrointestinal internal heat-type clinical symptoms, and treatment effectiveness for metabolic dysfunction-associated fatty liver disease. There were no serious adverse reactions during the treatment.

Registration number

ChiCTR2200057237.

Funding

This study was supported by the Hangzhou Medicine and Health Science and Technology Program and Hangzhou Lin'an District Hospital of Traditional Chinese Medicine.

导言:在全球范围内,肥胖症的发病率越来越高,导致高血压、糖尿病和心血管疾病的发病率增加。穴位埋线是中国流行的一种针灸方法,在控制体重方面比针灸更有效。方法在这项随机对照试验中,60 名胃肠道内热型肥胖患者被随机分为干预组(30 人)和对照组(30 人)。干预组在饮食和运动的基础上进行为期 2 个月的猫肠嵌入治疗,猫肠治疗频率为每 10 天一次,每次 30 分钟。对照组在同一时期只进行饮食和运动。对治疗前后的体重、体重指数(BMI)、腰臀比(WHR)、空腹血浆葡萄糖、2 小时血糖、糖化血红蛋白和血脂水平进行了评估。2 个月后,与对照组相比,干预组的 WHR 和胃肠道内热型临床症状总分均呈显著下降趋势(平均差:-0.03,95% 置信度(P<0.05)):-0.03,95% 置信度 [CI]:平均差:-0.03,95%置信水平[CI]:-0.07 至 0.00,平均差:-6.04,95%置信水平[CI]:-0.00分别为-6.04,95% 置信度[CI]:-8.59 至-3.50)。在干预组中,体重和体重指数的平均降幅分别为 6.18 千克(95% CI:4.60 至 7.76)和 2.23 千克/平方米(95% CI:1.72 至 2.74)。干预组和对照组治疗脂肪肝的总有效率分别为 61.5%和 30.8%(风险比:3.60;95% CI:1.14 至 11.35)。干预组在体重、体重指数、WHR、胃肠道内热型临床症状总分以及代谢功能障碍相关性脂肪肝的治疗效果方面均优于对照组。本研究得到了杭州市医药卫生科技项目和杭州市临安区中医院的支持。
{"title":"The effects of catgut embedding in patients with obesity of gastrointestinal internal heat: A randomised controlled trial","authors":"Qingqing Zhu ,&nbsp;Jian Cheng ,&nbsp;Xiaolan Xu ,&nbsp;Tangying Xu ,&nbsp;Xingjiang Gu ,&nbsp;Yun Xia ,&nbsp;Lingzhen Mao ,&nbsp;Nannan Hu ,&nbsp;Yuexia Fang","doi":"10.1016/j.eujim.2023.102327","DOIUrl":"10.1016/j.eujim.2023.102327","url":null,"abstract":"<div><h3>Introduction</h3><p>Globally, the incidence of obesity is increasing, causing increased rates of hypertension, diabetes, and cardiovascular diseases. Acupoint catgut embedding, a popular acupuncture method in China, has greater efficacy than acupuncture for weight control. The effectiveness of catgut embedding in patients with fatty liver associated with metabolic dysfunction was investigated.</p></div><div><h3>Methods</h3><p>In this randomised controlled trial, 60 patients with gastrointestinal internal heat-type obesity were randomised to the intervention (<em>n</em> = 30) and control (<em>n</em> = 30) groups. The intervention group participated in the catgut embeddings with diet and exercise for 2 months, with a catgut treatment frequency of once every 10 days for 30 min. The control group participated only in diet and exercise for the same period. Body weight; body mass index (BMI); waist-to-hip ratio (WHR); fasting plasma glucose, 2-hour blood glucose, glycated haemoglobin, and lipid levels were assessed before and after treatments.</p></div><div><h3>Results</h3><p>Fifty-seven patients completed the courses. After 2 months, the intervention group showed a statistically significant trend of decrease in WHR and total score of gastrointestinal internal heat-type clinical symptoms when compared with the control group (mean difference: −0.03, 95 % confidence level [CI]: −0.07 to 0.00 and mean difference: −6.04, 95 % CI: −8.59 to −3.50, respectively). In the intervention group, the mean reductions in body weight and BMI were 6.18 kg (95 % CI: 4.60 to 7.76) and 2.23 kg/m<sup>2</sup> (95 % CI: 1.72 to 2.74), respectively. The total treatment efficiency for fatty liver in the intervention and control groups was 61.5 % and 30.8 %, respectively (risk ratio: 3.60; 95 % CI: 1.14 to 11.35).</p></div><div><h3>Conclusion</h3><p>Catgut embedding administered with diet and exercise is effective for patients with gastrointestinal internal heat-type obesity and some patients with obesity complicated by metabolic dysfunction-associated fatty liver disease. The effects observed in the intervention group were superior to those in the control group in terms of body weight, BMI, WHR, total score of gastrointestinal internal heat-type clinical symptoms, and treatment effectiveness for metabolic dysfunction-associated fatty liver disease. There were no serious adverse reactions during the treatment.</p></div><div><h3>Registration number</h3><p>ChiCTR2200057237.</p></div><div><h3>Funding</h3><p>This study was supported by the Hangzhou Medicine and Health Science and Technology Program and Hangzhou Lin'an District Hospital of Traditional Chinese Medicine.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"66 ","pages":"Article 102327"},"PeriodicalIF":2.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876382023001038/pdfft?md5=1e0505cc3272ba77d025c5185e34708c&pid=1-s2.0-S1876382023001038-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138683913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Korean medicine therapies in children with allergic rhinitis: A prospective, multicenter, observational registry study at primary-care network clinics 过敏性鼻炎患儿的韩药联合疗法:初级保健网络诊所的前瞻性多中心观察登记试验
IF 2.5 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-02-01 DOI: 10.1016/j.eujim.2024.102336
Hongmin Chu , EunKyoung Lee , Seunghwan Moon PharmB , Hamsoa Clinics KM Doctors Group , Bo-Hyoung Jang

Introduction

Allergic rhinitis (AR) causes symptoms such as hyper-rhinorrhea, sneezing, nasal congestion, itching, and pain by triggering inflammation in the nasal mucosa and an immune response caused by antigen-specific Immunoglobulin E (IgE). This prospective multicenter observational study aimed to evaluate the symptoms change and safety of combined Korean medicine (KM) therapy in patients with AR.

Methods

This study was conducted in HAMSOA Korean Medicine Clinics, a network specializing in treating pediatric patients in Korea, and 15 centers participated. The patients were divided into three groups (mild, moderate, and severe) according to their baseline total nasal symptom score. The patients were treated with herbal medicine, acupuncture, cupping therapy, and moxibustion therapy.

Results

The study involved 72 subjects aged 6.47 ± 2.37 years. The average Numeric Rating Scale for allergic rhinitis symptoms at the baseline and final follow-up were 4.39 ± 2.14 to 3.47 ± 2.51, respectively, indicating a significant improvement over an average of 4 weeks. The Pediatric Allergic Disease Quality of Life Questionnaire scores at the final screening improved in all three groups. The mean difference was -10.44, with a 95 % confidence interval of -15.35 to -5.54 (p < 0.01.). Furthermore, no adverse events were reported in any patient in this study.

Conclusion

The results provide preliminary evidence suggesting that KM treatment may be a safe and effective option for reducing symptoms associated with allergic rhinitis in children. Additional prospective studies are required to confirm the results of the present study.

导言过敏性鼻炎(AR)通过引发鼻粘膜炎症和由抗原特异性免疫球蛋白E(IgE)引起的免疫反应,导致流鼻涕、打喷嚏、鼻塞、瘙痒和疼痛等症状。这项前瞻性多中心观察性研究旨在评估韩医(KM)联合疗法对 AR 患者的症状变化和安全性。方法这项研究在 HAMSOA 韩医诊所(韩国专门治疗儿科患者的网络)进行,共有 15 个中心参与。根据患者鼻部症状的基线总评分,将其分为三组(轻度、中度和重度)。患者接受了中药、针灸、拔罐和艾灸治疗。在基线和最终随访中,过敏性鼻炎症状的平均数值评定量表分别为(4.39±2.14)分和(3.47±2.51)分,这表明在平均 4 周的时间内,过敏性鼻炎症状有了显著改善。三组患者在最终筛查时的儿科过敏性疾病生活质量问卷得分均有所提高。平均差异为-10.44,95%置信区间为-15.35至-5.54(p<0.01)。结论:研究结果提供了初步证据,表明 KM 治疗可能是减少儿童过敏性鼻炎相关症状的一种安全有效的选择。要证实本研究的结果,还需要进行更多的前瞻性研究。
{"title":"Combined Korean medicine therapies in children with allergic rhinitis: A prospective, multicenter, observational registry study at primary-care network clinics","authors":"Hongmin Chu ,&nbsp;EunKyoung Lee ,&nbsp;Seunghwan Moon PharmB ,&nbsp;Hamsoa Clinics KM Doctors Group ,&nbsp;Bo-Hyoung Jang","doi":"10.1016/j.eujim.2024.102336","DOIUrl":"10.1016/j.eujim.2024.102336","url":null,"abstract":"<div><h3>Introduction</h3><p>Allergic rhinitis (AR) causes symptoms such as hyper-rhinorrhea, sneezing, nasal congestion, itching, and pain by triggering inflammation in the nasal mucosa and an immune response caused by antigen-specific Immunoglobulin E (IgE). This prospective multicenter observational study aimed to evaluate the symptoms change and safety of combined Korean medicine (KM) therapy in patients with AR.</p></div><div><h3>Methods</h3><p>This study was conducted in HAMSOA Korean Medicine Clinics, a network specializing in treating pediatric patients in Korea, and 15 centers participated. The patients were divided into three groups (mild, moderate, and severe) according to their baseline total nasal symptom score. The patients were treated with herbal medicine, acupuncture, cupping therapy, and moxibustion therapy.</p></div><div><h3>Results</h3><p>The study involved 72 subjects aged 6.47 ± 2.37 years. The average Numeric Rating Scale for allergic rhinitis symptoms at the baseline and final follow-up were 4.39 ± 2.14 to 3.47 ± 2.51, respectively, indicating a significant improvement over an average of 4 weeks. The Pediatric Allergic Disease Quality of Life Questionnaire scores at the final screening improved in all three groups. The mean difference was -10.44, with a 95 % confidence interval of -15.35 to -5.54 (<em>p</em> &lt; 0.01.). Furthermore, no adverse events were reported in any patient in this study.</p></div><div><h3>Conclusion</h3><p>The results provide preliminary evidence suggesting that KM treatment may be a safe and effective option for reducing symptoms associated with allergic rhinitis in children. Additional prospective studies are required to confirm the results of the present study.</p></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"66 ","pages":"Article 102336"},"PeriodicalIF":2.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139510331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1